endogenous glp-1 and the kidney: from physiology to pharmacology and outcomes in diabetes Glucagon‐like peptide‐1: Are its roles

So they start assuming that if something is good topically, its even better when injected

doi:10.1136/bmj-2025-085304 45.Lillys Foundayo and lower-dose Zepbound helped people maintain weight loss after switching from higher doses of injectable incretin therapy in two late-phase trials

The return of metabolism: biochemistry and physiology of the pentose phosphate pathway

Generic Ozempic may arrive with significant savings, but sponsors who press carriers on day-one strategy will see that money hit their bottom line, argues Jean-Phillipe Bernard The arrival of generic Ozempic in 2026 could hand plan sponsors a cost reduction of about three per cent on average but only if they act before the window closes